Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Super Hi International Holding ADR | HDL | Nov 22, 2024 | 16.29 | -1.15 |
Super League Enterprise | SLE | Nov 22, 2024 | 0.61 | +0.16 |
Super Micro Computer | SMCI | Nov 22, 2024 | 33.15 | +11.62 |
Supercom | SPCB | Nov 22, 2024 | 3.68 | +4.55 |
Superior Group of Companies | SGC | Nov 22, 2024 | 16.64 | +1.09 |
Superior Industries International | SUP | Nov 22, 2024 | 2.38 | -2.06 |
Supernus Pharmaceuticals | SUPN | Nov 22, 2024 | 36.22 | +1.12 |
Surf Air Mobility | SRFM | Nov 22, 2024 | 2.68 | +6.77 |
SurgePays | SURG | Nov 22, 2024 | 1.75 | -2.78 |
Surgery Partners | SGRY | Nov 22, 2024 | 23.01 | -1.46 |
Surmodics | SRDX | Nov 22, 2024 | 39.33 | +0.36 |
Suro Capital | SSSS | Nov 22, 2024 | 5.05 | +2.85 |
Surrozen | SRZN | Nov 22, 2024 | 9.15 | -1.61 |
Sutro Biopharma | STRO | Nov 22, 2024 | 2.51 | -0.79 |
Suzano ADR | SUZ | Nov 22, 2024 | 10.49 | -0.66 |
Sweden Index MSCI Ishares | EWD | Nov 22, 2024 | 38.14 | +0.90 |
Sweetgreen | SG | Nov 22, 2024 | 43.40 | +5.21 |
Swiftmerge Acquisition A | IVCP | Nov 22, 2024 | 11.16 | +0.72 |
Swiftmerge Acquisition Unit | IVCPU | Nov 22, 2024 | 11.10 | 0.00 |
Swiss Franc Trust | FXF | Nov 22, 2024 | 99.33 | -0.86 |
Swiss Helvetia Fund | SWZ | Nov 22, 2024 | 7.80 | -0.23 |
Switzerland Alphadex First Trust | FSZ | Nov 22, 2024 | 64.36 | -0.20 |
Switzerland Index MSCI Ishares | EWL | Nov 22, 2024 | 47.28 | +0.19 |
SWK Holdings | SWKH | Nov 22, 2024 | 15.89 | +4.20 |
Swvl Holdings A | SWVL | Nov 22, 2024 | 6.16 | -4.79 |
SYLA Technologies Co., Ltd. - American Depositary Shares | SYT | Nov 22, 2024 | 1.63 | -2.40 |
Sylvamo | SLVM | Nov 22, 2024 | 90.90 | +2.48 |
Symbotic | SYM | Nov 22, 2024 | 38.78 | +6.93 |
Synaptics | SYNA | Nov 22, 2024 | 76.50 | +2.49 |
Synaptogenix | SNPX | Nov 22, 2024 | 2.60 | +1.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.